Nexium, Esomeprazole News

The FDA has issued a public health advisory warning consumers to avoid using the stomach acid reducer omeprazole, which is marketed in prescription and OTC formulations as Prilosec, with the anticlotting drug clopidogrel, which is marketed as Plavix.

Although gastroesophageal reflux disease is common in adolescents, the burden of GERD on health-related quality of life in adolescents has not been previously evaluated.

The popular heartburn drugs Prilosec and Nexium can reduce by nearly half the blood thinning effect of the drug Plavix, said officials with the U.S. Food and Drug Administration on Tuesday.

Patients who are taking clopidogrel should avoid the concomitant use of omeprazole, a proton-pump inhibitor , because the latter drug diminishes the antiplatelet effects of clopidogrel, FDA announced today.

The drug is indicated in case of gastroesophageal reflux disease. The innovator has objected to all the five filings that Lupin has made in its Abbreviated New Drug Application to the US Food and Drug Administration to market the generic version of Nexium with strength 20 and 40 mg.

Main Category: GastroIntestinal / Gastroenterology Also Included In: Arthritis / Rheumatology Clinical Trials / Drug Trials AstraZeneca and POZEN Inc.

The latest issue of the Alimentary Pharmacology & Therapeutics compares standard- with double-dose proton pump inhibitors for the healing of severe erosive esophagitis.

POZEN Inc. , announced that the U.S. Food and Drug Administration has accepted the New Drug Application for VIMOVO .

BOSTON Drugs commonly used to treat heartburn and acid-reflux disease dona t interfere with drugs used to prevent clotting in patients with heart disease, according to a new study.

VIMOVO is a fixed-dose combination of enteric-coated naproxen, a pain-relieving non-steroidal anti-inflammatory drug and immediate release esomeprazole, a proton pump inhibitor , under investigation for the treatment of the signs and symptoms of osteoarthritis , rheumatoid arthritis and ankylosing spondylitis in patients who are at risk of ...

Prilosec, Nexium, Prevacid, Aciphex. These and a dozen more drugs known as proton pump inhibitors have quickly become superstars of Big Pharma.

Abstract Researchers find that treating 'silent' acid reflux has no effect on asthma.

What's the latest news in the medical journals this month? Find out what your doctor is reading.

Researchers in the latest American Journal of Gastroenterology find that eradicating Helicobacter pylori infection is necessary in patients using long-term esomeprazole for reflux esophagitis.

To the Editor: In their article on the use of esomeprazole in patients with poorly controlled asthma ,1 Mastronarde et al.

PUMP INHIBITORS that are used to treat acid reflux have been associated with an increased risk for pneumonia, according to a recent study.

Popular antacids known as proton pump inhibitors , or PPIs , may cause or aggravate the very acid-reflux symptoms they're used to treat, according to a new study.

After proton pump inhibitor therapy is withdrawn, patients may be likely to experience acid-related symptoms, according to a study published in the July issue of Gastroenterology .

Jun 30, 2009 - POZEN Inc. , today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the marketing approval of VIMOVO , the combination of enteric coated naproxen and immediate release esomeprazole.

New Study Shows Nexium 40 Mg And 20 Mg Reduced Gastric And Duodenal Ulcers By 80 - 85% In Patients Taking Low-Dose Aspirin For CV Protection Esomeprazole significantly reduced the occurrence of gastric and duodenal ulcers and upper gastrointestinal symptoms in patients taking low-dose aspirin for risk reduction of adverse cardiovascular events[i], ...